Intra-cellular Therapies, Inc. (ITCI) Earnings
|
Expand Research on ITCI
| Next EPS Date | 5/8/24 | EPS Growth Rate | +28.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +34.3% | Revenue Growth Rate | +46.8% |
| Average % Move 1-Wk after EPS | +1.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/22/24 | Q423 | -$0.30 | -$0.45 | +$0.15 | $132.21M | $136.27M | = |  | | Details | |
| 11/2/23 | Q323 | -$0.25 | -$0.56 | +$0.31 | $126.17M | $119.72M | = | | | Details | |
| 8/3/23 | Q223 | -$0.45 | -$0.59 | +$0.14 | $110.8M | $106.54M | = | | | Details | |
| 5/4/23 | Q123 | -$0.46 | -$0.61 | +$0.15 | $95.3M | $91.4M | = | | | Details | |
| 3/1/23 | Q422 | -$0.45 | -$0.59 | +$0.14 | $87.87M | $86.89M | = | | | Details | |
| 11/3/22 | Q322 | -$0.57 | -$0.81 | +$0.24 | $71.9M | $65.88M | N/A | | | Details | |
8/5/15  |
 |
Q215 | -$0.61 | -$0.72 | +$0.11 | $57.4M | $40K | N/A | | | Details |
| 8/9/22 |
Q222 | -$0.92 | -$0.76 | -$0.16 | $55.6M | $49.08M | N/A | | | Details |
